Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
COVID-19 may attack arteries, increase risk to heart, study finds
Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...
labiotech13h
Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients
Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...
Hosted on MSN8h
ABC Asks Judge To Shut Down General Hospital Alum Ingo Rademacher’s Plea
ABC has claimed that Ingo Rademacher's argument that Steve Burton's rehiring was not new evidence and has no bearing on his ...
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Cancer vaccine shows promise for patients with stage III and IV kidney cancer
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
The American Journal of Managed Care11h
Promising Cancer Vaccine Boosts Hope for Stage III and IV Kidney Cancer
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.
Harvard Medical School16h
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
emjreviews.com20h
Repurposing COVID-19 Vaccines for Effective Cancer Therapy
To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...